Vir Biotechnology VIR
NASDAQ VIR
$10.74 +0.53 (+5.19%)
At close: Oct 20, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Receivables - Net (2020 - 2022)

Updated

Vir Biotechnology (VIR) posted Receivables - Net of $7 million for Q2 2022, down 99.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Receivables - Net (2020 - 2022) Analysis & Trends

At the end of FY2021, Vir Biotechnology's Receivables - Net came in at $773.08 million.

  • The Q2 2022 figure stands as the lowest quarterly Receivables - Net since Q2 2020.
  • According to Business Quant data, Receivables - Net for the three prior quarters was $1.22 billion (Q1 2022), $773.08 million (Q4 2021) and $93 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Vir Biotechnology 1.80 Bn -159.02 Mn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 7.00 Mn
Mar 31, 2022 1.22 Bn
Dec 31, 2021 773.08 Mn
Sep 30, 2021 93.00 Mn
Mar 31, 2021 112.50 Mn
Jun 30, 2020 3.80 Mn
API Access

Vir Biotechnology Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=VIR&period=max&api_key=YOUR_API_KEY